Yahoo Finance • 4 days ago
Novo Nordisk A/S Bagsværd, Denmark, 5 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance wit... Full story
Yahoo Finance • 4 days ago
Image source: The Motley Fool. DATE Wednesday, October 29, 2025 at 10 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Emma Walmsley Chief Commercial Officer — Luke Miels President, ViiV Healthcare — Deborah Waterhouse Chief Financi... Full story
Yahoo Finance • 4 days ago
LONDON, Feb. 5, 2026 /PRNewswire/ -- BioPhorum, the pharmaceutical industry's most trusted collaborative network for change, today announces the formation of its inaugural Strategic Advisory Board.The biopharmaceutical industry’s most trus... Full story
Yahoo Finance • 5 days ago
Taiwan’s new vehicle market was unchanged at 35,073 units in January 2026, compared with 35,064 units in the same month last year, according to registration data compiled by Taiwan’s Ministry of Transportation. Despite more working days i... Full story
Yahoo Finance • 6 days ago
Leerink analyst Roanna Ruiz was not surprised that Aquestive Therapeutics (AQST) received a Complete Response Letter for Anaphylm given the FDA’s prior deficiency letter. That said, the “silver lining” is that this outcome appears recovera... Full story
Yahoo Finance • 6 days ago
WASHINGTON, Feb. 3, 2026 /PRNewswire/ -- Glencore and the Orion Critical Mineral Consortium ("Orion CMC") announce that they have entered into a non-binding Memorandum of Understanding in relation to a potential acquisition by Orion CMC of... Full story
Yahoo Finance • 6 days ago
Oslo, Norway, 03 February 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announced the promotion of Emilie... Full story
Yahoo Finance • 6 days ago
Oslo, Norge – 3. februar 2026 – Zelluna (OSE: ZLNA), et selskap som utvikler allogene "off-the-shelf" T-cellereseptor-baserte Natural Killer (TCR-NK) celleterapier for behandling av kreft, kunngjorde i dag utnevnelsen av Emilie Gauthy til... Full story
Yahoo Finance • 6 days ago
By Tom Westbrook SINGAPORE, Feb 3 (Reuters) - Gold and Asian stocks were on the rebound on Tuesday as trade took a calmer tone after wild swings in metals markets, with the mood helped by a sharp jump in U.S. factory activity, while the... Full story
Yahoo Finance • 7 days ago
What happened According to an SEC filing dated Feb. 2, 2026, Artemis Investment Management LLP initiated a new stake in Commercial Metals Company(NYSE:CMC) by acquiring 1,501,906 shares during the fourth quarter. The estimated transaction... Full story
Yahoo Finance • 7 days ago
TL;DR: Macro: Bitcoin breaks down; Fear hits 15; altcoins capitulate. AI sector: $2.7B erased; down 14.8% WoW; broad red. Standouts: CLANKER, SENT, FHE gain; agents mixed; catalysts partly unclear. Last week was… eventful, to say the lea... Full story
Yahoo Finance • 7 days ago
SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ -- On January 11, as the global healthcare industry gathered in San Francisco, the BIOSeedin Winter Innovation Partnering Summit successfully convened ahead of J.P. Morgan 2026. ACROBiosystems, as a... Full story
Yahoo Finance • last month
SAN FRANCISCO, Dec. 31, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lea... Full story
Yahoo Finance • last month
[Countdown to 2026. Loading year from 2025 to 2026. New year start concept.] SmileStudioAP J.P. Morgan identifies specific traits that define their Best Ideas for 2026. These companies typically possess: * Strong Financial Health: Rob... Full story
Yahoo Finance • last month
[US Food and Drug Administration (FDA)] Ultragenyx Pharmaceutical (RARE [https://seekingalpha.com/symbol/RARE]) has completed the rolling submission of its U.S. marketing application for its gene therapy candidate DTX401 for a rare disord... Full story
Yahoo Finance • last month
ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2025 a... Full story
Yahoo Finance • last month
TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today issued the following letter to share... Full story
Yahoo Finance • last month
SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lea... Full story
Yahoo Finance • last month
LOS ANGELES, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or other... Full story
Yahoo Finance • last month
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Telix between February 21... Full story